Home > Insider Trading > Filing (0001209191-21-028843)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1671818	Oncorus Inc.	ONCR	Pharmaceutical Preparations (2834)	473779757

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1826523	Christophe Queva	C/O Oncorus, Inc. 50 Hampshire Street, Suite 401 Cambridge MA 02139	Cso And Svp, Research	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-04-26	54	$15.00	77,376	No	4	S	Direct
Common Stock	Disposition	2021-04-27	211	$15.00	77,165	No	4	S	Direct
Common Stock	Disposition	2021-04-28	17,990	$15.22	59,175	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Shares were sold pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to$15.04 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth infootnote (2) and (3).
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.47 inclusive.